ArticlePharmaceuticals (Basel, Switzerland)2026

The Sigma-1 Receptor Agonist Fluvoxamine Is Protective in Hyperglycaemia-Induced Dysfunction of Trabecular Meshwork Cells.

Alexandra Rozsahegyi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.